The Influence of the Coadministration of the P-Glycoprotein Modulator Elacridar on the Pharmacokinetics of Lapatinib and Its Distribution in the Brain and Cerebrospinal Fluid
Investigational New Drugs - Netherlands
doi 10.1007/s10637-019-00806-3
Full Text
Open PDFAbstract
Available in full text
Date
June 8, 2019
Authors
Publisher
Springer Science and Business Media LLC